Previous 10 | Next 10 |
home / stock / bayry / bayry news
German conglomerate Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) announced on Tuesday that the U.S. Food and Drug Administration (FDA) granted the priority review and accepted its supplemental New Drug Application ((sNDA)) for prostate cancer therapy Nubeqa. With the sNDA, Bayer (OTCPK:BAYRY) has reques...
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...
The Food and Drug Administration (FDA) granted priority review to AstraZeneca's (NASDAQ:AZN) application for a single priming dose of tremelimumab added to Imfinzi (durvalumab) to treat patients with unresectable hepatocellular carcinoma, a type of liver cancer. The British drugmaker's had su...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The war in Ukraine has catalyzed greater alignment among ...
Bayer (OTCPK:BAYZF) has named Tara Frenkl as the new head of oncology development at its oncology strategic business unit beginning April 25. Frenkl was SVP, head of medicine development leaders in oncology at GlaxoSmithKline (GSK). Prior to GSK, Frenkl spent 13 years at Merck (MRK). Frenkl i...
The risk of double-digit inflation is real, as soaring commodity and agricultural input prices could have lagging and lasting effects on food prices. Cash is a traditional alternative to U.S. Treasuries from a diversification standpoint, but soaring inflation limits its typical store ...
We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...
We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...
We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by managers who think and act as owne...
As most of you know, Putin's horrific invasion of Ukraine has broken a crucial link in the global food supply chain. According to the WSJ, Russia and Ukraine supply roughly one-third of the world's wheat and 25% of the planet's barley. That being the case, and no sign that the war...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...